Lei Jianping on December 17
Health 160 International Limited ("Health 160") has submitted a prospectus to be listed on the Hong Kong Stock Exchange.
The annual revenue was 526 million and the loss during the period was 120 million
Health 160 is a digital healthcare service platform that connects healthcare institutions, medical staff and individual users to build a comprehensive healthcare service platform that seamlessly integrates online and offline channels.
As of 30 June 2023, the Health160 platform has connected more than 30,000 healthcare institutions, including more than 14,000 hospitals (including 3,295 tertiary hospitals) and more than 16,000 primary healthcare institutions.
As at the same date, about 6,600 private healthcare institutions in Health160's partner healthcare institutions mainly provide consumer medical services, such as dental, ophthalmology and health check-up services, on Health160's platform. In addition, Health160 has established partnerships with more than 720,000 healthcare professionals.
At the same time, Health160's platform has a large user base, with 44.9 million registered individual users as of June 30, 2023, and an average of 3 million average monthly active users for the six months ended June 30, 2023.
According to the prospectus, the revenue of Health 160 in 2020, 2021 and 2022 will be 279 million yuan, 423 million yuan and 526 million yuan respectively, the operating loss will be 14.21 million yuan, 139 million yuan and 79.18 million yuan respectively, and the loss during the period will be 29.88 million yuan, 152 million yuan and 120 million yuan respectively.
Health 160's revenue in the first half of 2023 was 269 million yuan, compared with 232 million yuan in the same period last year, and the operating loss was 19.98 million yuan, compared with an operating loss of 30.47 million yuan in the same period last year, and the loss for the period was 24.78 million yuan, compared with a loss of 52.16 million yuan in the same period last year.
As of June 30, 2023, Health 160 held cash and cash equivalents of $57.44 million.
It has just completed 50 million yuan in financing
After the track record period, Health 160 received capital injection from an investor, LSJC Holdings, who agreed to subscribe for 1,039,069 shares. The consideration is RMB50 million, which was fully settled on November 28, 2023.
The executive directors are Luo Ningzheng, Ji Cuilin, Huang Lang and Wang Fafang, the non-executive directors are Zhang Ruxie and Ms. Sun Meng, and the independent non-executive directors are Zou Jun, Dr. Xu Weiguo and Dr. Fan Ming.
As of the Latest Practicable Date, Luo Ningzheng controlled approximately 33.99% of the voting rights through its wholly-owned subsidiaries (LNZ Management Limited and Luo Holdings Limited).
此外，QF CY持股为5.91%，160 Future持股为4.57%，CX 160持股为4.44%，QF ZSCY持股为4.44%，芜湖领航持股为4.31%，Ming Holdings Limited持股为3.87%，广州领康持股为2.18%，分享择善、分享以道分别持股为2.11%，Ineffable Dream Limited持股为2.07%；
Shenzhen Investment Holding Donghai holds 1.9%, Shenzhen Chengyu and LSJC Holdings hold 1.72% respectively, Gorgeous Ocean Holding Limited holds 1.69%, QF CXHL holds 1.37%, QF JR holds 1.36%, YINKANG holds 1.26%, Chongqing Southern Fund holds 1.25%, Jiangsu Qiquan holds 1.22%, and Huzhou Yashang holds 1.14% , Qingdao Litan Haipeng holds 1.12%;
QF Morris Limited持股为1.04%，青岛立檀持股为0.98%，QF FZK Limited持股为0.96%，160 Health Future持股为0.95%，WL Management Limited持股为0.94%，南京富睿持股为0.92%，珠海旭华持股为0.88%，JYQ Holding、QF HL分别持股为0.84%；
深圳远致持股为0.68%，盈信国富持股为0.57%，QF HT持股为0.5%，LFL Limited、YYN Holdings Limited、清科嘉启、清科易聚、清科小池、HQYZ分别持股为0.42%；
Zhonghui Management、乐致厦门分别持股为0.34%，FJH Limited持股为0.26%，深圳龙骏持股为0.21%，HXY Limited持股为0.17%。
———————————————
Lei Di was founded by Lei Jianping, a media person, if it is reprinted, please indicate the source.